Related Experiment Video
Updated: Oct 6, 2025
Author Spotlight: Studying Host-Virus Interactions with Pseudotyped Viruses
Published on: November 21, 2023
The SARS-CoV-2 mutations versus vaccine effectiveness: New opportunities to new challenges
Jonaid Ahmad Malik1, Sakeel Ahmed2, Aroosa Mir3
1Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Guwahati, India; Department of Biomedical Engineering, Indian Institute of Technology (IIT), Ropar 140001, India.
Background:
The SARS-CoV-2 coronavirus epidemic is hastening the discovery of the most efficient vaccines. The development of cost-effective vaccines seems to be the only solution to terminate this pandemic. However, the vaccines' effectiveness has been questioned due to recurrent mutations in the SARS-CoV-2 genome. Most of the mutations are associated with the spike protein, a vital target for several marketed vaccines. Many countries were highly affected by the 2nd wave of the SARS-CoV-2, like the UK, India, Brazil and France. Experts are also alarming the further COVID-19 wave with the emergence of Omicron, which is highly affecting the South African populations. This review encompasses the detailed description of all vaccine candidates and COVID-19 mutants that will add value to design further studies to combat the COVID-19 pandemic.
Methods:
The information was generated using various search engines like google scholar, PubMed, clinicaltrial.gov.in, WHO database, ScienceDirect, and news portals by using keywords SARS-CoV-2 mutants, COVID-19 vaccines, efficacy of SARS-CoV-2 vaccines, COVID-19 waves.
Results:
This review has highlighted the evolution of SARS-CoV-2 variants and the vaccine efficacy. Currently, various vaccine candidates are undergoing several phases of development. Their efficacy still needs to check for newly emerged variants. We have focused on the evolution, multiple mutants, waves of the SARS-CoV-2, and different marketed vaccines undergoing various clinical trials and the design of the trials to determine vaccine efficacy.
Conclusion:
Various mutants of SARS-CoV-2 arrived, mainly concerned with the spike protein, a key component to design the vaccine candidates. Various vaccines are undergoing clinical trial and show impressive results, but their efficacy still needs to be checked in different SARS-CoV-2 mutants. We discussed all mutants of SARS-CoV-2 and the vaccine's efficacy against them. The safety concern of these vaccines is also discussed. It is important to understand how coronavirus gets mutated to design better new vaccines, providing long-term protection and neutralizing broad mutant variants. A proper study approach also needs to be considered while designing the vaccine efficacy trials, which further improved the study outcomes. Taking preventive measures to protect from the virus is also equally important, like vaccine development.
Insights
The development of effective COVID-19 vaccines is crucial, but mutations in the SARS-CoV-2 virus, particularly in the spike protein, challenge their efficacy. Ongoing research evaluates vaccine candidates against emerging variants to ensure long-term protection.
Area of Science:
- Virology and Immunology
- Vaccine Development
- Epidemiology
Background:
- The SARS-CoV-2 pandemic necessitates rapid vaccine development, but viral mutations pose a significant challenge to vaccine effectiveness.
- Mutations primarily affect the spike protein, a key target for current vaccines, raising concerns about ongoing and future COVID-19 waves.
- Emerging variants like Omicron highlight the urgent need for adaptable and broadly protective vaccine strategies.
Purpose of the Study:
- To review the evolution of SARS-CoV-2 mutants and assess the efficacy of existing and developing COVID-19 vaccines.
- To provide a comprehensive overview of vaccine candidates, viral variants, and clinical trial designs for evaluating vaccine effectiveness.
- To inform future research and development efforts for more robust and mutation-resistant vaccines.
Main Methods:
- Literature search using academic databases (Google Scholar, PubMed) and official sources (WHO, ClinicalTrials.gov).
- Keywords included "SARS-CoV-2 mutants," "COVID-19 vaccines," "vaccine efficacy," and "COVID-19 waves."
- Analysis of information on viral evolution, vaccine candidates, and clinical trial methodologies.
Main Results:
- The review highlights the continuous evolution of SARS-CoV-2 variants and their impact on vaccine efficacy.
- Multiple vaccine candidates are in development, but their effectiveness against new mutants requires further evaluation.
- Focus is placed on understanding viral mutations, vaccine trial designs, and the efficacy of marketed vaccines against diverse variants.
Conclusions:
- Understanding SARS-CoV-2 mutations, especially in the spike protein, is vital for designing effective vaccines.
- While current vaccines show promise, their efficacy against various mutants needs thorough assessment, including safety considerations.
- Developing vaccines with long-term protection and broad neutralization capabilities against diverse variants is essential, alongside continued preventive measures.
More Related Videos
08:41Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
06:08Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research
Published on: September 8, 2023
Related Concept Videos
00:36Viral Mutations
01:05Single Nucleotide Polymorphisms-SNPs
01:18Mutations in Microorganisms
01:29Microorganisms in Medicine and Therapeutics
01:51Vaccinations
01:03Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...